肾移植受者的渗透压调节能力与移植结局相关
这项单中心前瞻性队列研究纳入1258例肾移植受者,移植后3个月行水负荷试验评估渗透压调节能力,并与164例健康候选者对照。受者水负荷时血钠下降斜率显著大于对照,且斜率越陡与全因死亡和移植物丢失复合结局及移植物丢失独立相关,并与12个月时mGFR较低独立相关。
要点
- 肾移植受者水负荷时血钠下降斜率明显大于健康对照。
- 血钠下降斜率越陡,全因死亡和移植物丢失风险越高。
- 血钠下降斜率越陡,移植后12个月mGFR越低。
核心结论
- 肾移植受者渗透压调节能力下降常见,且是肾脏结局的独立预测因素。
研究设计与样本
- 单中心前瞻性队列研究,纳入1258例肾移植受者,移植后3个月行水负荷试验并测mGFR,164例健康候选者作对照。
主要发现
- 水负荷时血钠斜率在受者为-0.6±0.4 mmol/L每小时,对照为-0.12±0.3 mmol/L每小时,P<0.001。
- 血钠每下降1 mmol/L每小时,全因死亡和移植物丢失复合结局HR为1.73(95%CI 1.23–2.45,P=0.002)。
- 血钠每下降1 mmol/L每小时,移植物丢失HR为2.04(95%CI 1.19–3.51,P=0.01)。
- 排除高血糖患者的预设敏感性分析中关联仍显著。
- 移植后3个月血钠斜率越陡与12个月mGFR较低独立相关(β=1.93;95%CI 0.46–3.41;P=0.01)。
临床怎么用
- 肾移植受者移植后3个月行水负荷试验评估渗透压调节能力,可能有助于识别不良结局高风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kidney transplant recipients have an impaired ability to dilute urine but seldom develop baseline hyponatremia before ESRD. Although hyponatremia is a risk factor for adverse events in CKD and in kidney transplant recipients, it remains unclear whether subtler alterations in osmoregulation performance are associated with outcome. METHODS: We studied a single-center prospective cohort of 1258 kidney transplant recipients who underwent a water-loading test 3 months after transplant to determine osmoregulation performance. Measured GFR (mGFR) was performed at the same visit. A group of 164 healthy candidates for kidney donation served as controls. We further evaluated the association of osmoregulation performance with transplantation outcomes and subsequent kidney function. RESULTS: Unlike controls, most kidney transplant recipients failed to maintain plasma sodium during water loading (plasma sodium slope of -0.6±0.4 mmol/L per hour in transplant recipients versus -0.12±0.3 mmol/L per hour in controls; P<0.001). Steeper plasma sodium reduction during the test independently associated with the composite outcome of all-cause mortality and allograft loss (hazard ratio [HR], 1.73 per 1 mmol/L per hour decrease in plasma sodium; 95% confidence interval [95% CI], 1.23 to 2.45; P=0.002) and allograft loss alone (HR, 2.04 per 1 mmol/L per hour decrease in plasma sodium; 95% CI, 1.19 to 3.51; P=0.01). The association remained significant in a prespecified sensitivity analysis excluding patients with hyperglycemia. In addition, a steeper plasma sodium slope 3 months after transplantation independently correlated with lower mGFR at 12 months (β=1.93; 95% CI, 0.46 to 3.41; P=0.01). CONCLUSIONS: Reduced osmoregulation performance occurs frequently in kidney transplant recipients and is an independent predictor of renal outcome.
引用
- Mazloum M, Jouffroy J, Brazier F, et al. Osmoregulation Performance and Kidney Transplant Outcome. J Am Soc Nephrol. 2019. PMID: 31217325. doi:10.1681/ASN.2018121269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。